TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
MittVaccin Sverige AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
34,961
|
35,154
|
24,390 |
| Financial expenses |
619
|
299
|
230 |
| Earnings before taxes |
9,414
|
9,968
|
2,324 |
| EBITDA |
10,082
|
12,336
|
4,626 |
| Total assets |
38,049
|
39,635
|
28,659 |
| Current assets |
38,049
|
39,435
|
26,387 |
| Current liabilities |
3,645
|
15,275
|
14,687 |
| Equity capital |
3,048
|
3,834
|
4,162 |
| - share capital |
881
|
881
|
881 |
| Employees (average) |
10
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
8.0%
|
9.7%
|
14.5% |
| Turnover per employee |
3,496
|
5,022
|
3,484 |
| Profit as a percentage of turnover |
26.9%
|
28.4%
|
9.5% |
| Return on assets (ROA) |
26.4%
|
25.9%
|
8.9% |
| Current ratio |
1043.9%
|
258.2%
|
179.7% |
| Return on equity (ROE) |
308.9%
|
260.0%
|
55.8% |
| Change turnover |
-193
|
10,764
|
-3,539 |
| Change turnover % |
-1%
|
44%
|
-13% |
| Chg. No. of employees |
3
|
0
|
2 |
| Chg. No. of employees % |
43%
|
0%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.